LY-300168

N/A

Report date: 2022/09/21 14:57:36
NME

Base Information

Drug NameLY-300168
Drug Alias NameGYKI-53655LY-300168
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA antagonists
TargetsGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsSeizures
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEgis PharmaceuticalsEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And CompanyNational Institute Of Neurological Disorders And Stroke
Active IndicationsN/A
Inactive IndicationsSeizures

Other Information

ATC CodeN/A
Related LinksN/A